Annual Total Assets
$787.22 M
+$24.55 M+3.22%
31 December 2023
Summary:
Ligand Pharmaceuticals Incorporated annual total assets is currently $787.22 million, with the most recent change of +$24.55 million (+3.22%) on 31 December 2023. During the last 3 years, it has fallen by -$575.07 million (-42.21%). LGND annual total assets is now -47.34% below its all-time high of $1.49 billion, reached on 31 December 2019.LGND Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Assets
$954.87 M
+$88.46 M+10.21%
30 September 2024
Summary:
Ligand Pharmaceuticals Incorporated quarterly total assets is currently $954.87 million, with the most recent change of +$88.46 million (+10.21%) on 30 September 2024. Over the past year, it has increased by +$185.64 million (+24.13%). LGND quarterly total assets is now -54.65% below its all-time high of $2.11 billion, reached on 30 September 2018.LGND Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LGND Total Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +3.2% | +24.1% |
| 3 y3 years | -42.2% | -25.0% |
| 5 y5 years | -37.6% | -38.3% |
LGND Total Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -42.2% | +3.2% | -26.4% | +25.9% |
| 5 y | 5 years | -47.3% | +3.2% | -38.3% | +25.9% |
| alltime | all time | -47.3% | +1585.7% | -54.6% | +2552.4% |
Ligand Pharmaceuticals Incorporated Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $954.87 M(+10.2%) |
| June 2024 | - | $866.40 M(-5.2%) |
| Mar 2024 | - | $913.87 M(+16.1%) |
| Dec 2023 | $787.22 M(+3.2%) | $787.22 M(+2.3%) |
| Sept 2023 | - | $769.23 M(+1.5%) |
| June 2023 | - | $758.11 M(-6.5%) |
| Mar 2023 | - | $811.08 M(+6.3%) |
| Dec 2022 | $762.67 M(-41.2%) | $762.67 M(-27.4%) |
| Sept 2022 | - | $1.05 B(-2.4%) |
| June 2022 | - | $1.08 B(-2.6%) |
| Mar 2022 | - | $1.11 B(-14.8%) |
| Dec 2021 | $1.30 B(-4.7%) | $1.30 B(+1.9%) |
| Sept 2021 | - | $1.27 B(+1.4%) |
| June 2021 | - | $1.26 B(-3.0%) |
| Mar 2021 | - | $1.30 B(-4.9%) |
| Dec 2020 | $1.36 B(-8.9%) | $1.36 B(+9.2%) |
| Sept 2020 | - | $1.25 B(+0.4%) |
| June 2020 | - | $1.24 B(+4.8%) |
| Mar 2020 | - | $1.19 B(-20.7%) |
| Dec 2019 | $1.49 B(+18.6%) | $1.49 B(-3.4%) |
| Sept 2019 | - | $1.55 B(-14.1%) |
| June 2019 | - | $1.80 B(-5.9%) |
| Mar 2019 | - | $1.91 B(+51.8%) |
| Dec 2018 | $1.26 B(+87.9%) | $1.26 B(-40.1%) |
| Sept 2018 | - | $2.11 B(+13.3%) |
| June 2018 | - | $1.86 B(+146.2%) |
| Mar 2018 | - | $754.67 M(+12.5%) |
| Dec 2017 | $671.02 M(+11.5%) | $671.02 M(+1.3%) |
| Sept 2017 | - | $662.34 M(+3.5%) |
| June 2017 | - | $640.02 M(+1.6%) |
| Mar 2017 | - | $629.72 M(+4.7%) |
| Dec 2016 | $601.59 M(+19.6%) | $601.59 M(+0.1%) |
| Sept 2016 | - | $600.87 M(-2.6%) |
| June 2016 | - | $616.80 M(+0.5%) |
| Mar 2016 | - | $613.44 M(+21.9%) |
| Dec 2015 | $503.06 M(+95.0%) | $503.06 M(-3.6%) |
| Sept 2015 | - | $521.70 M(+71.2%) |
| June 2015 | - | $304.76 M(+15.8%) |
| Mar 2015 | - | $263.22 M(+2.0%) |
| Dec 2014 | $258.03 M(+146.4%) | $258.03 M(-5.2%) |
| Sept 2014 | - | $272.28 M(+172.7%) |
| June 2014 | - | $99.85 M(-5.3%) |
| Mar 2014 | - | $105.47 M(+0.7%) |
| Dec 2013 | $104.71 M(+0.4%) | $104.71 M(+3.0%) |
| Sept 2013 | - | $101.68 M(+2.1%) |
| June 2013 | - | $99.57 M(+1.2%) |
| Mar 2013 | - | $98.36 M(-5.7%) |
| Dec 2012 | $104.26 M(-13.5%) | $104.26 M(+6.9%) |
| Sept 2012 | - | $97.51 M(-6.8%) |
| June 2012 | - | $104.59 M(-6.4%) |
| Mar 2012 | - | $111.80 M(-7.3%) |
| Dec 2011 | $120.58 M(+59.6%) | $120.58 M(-1.5%) |
| Sept 2011 | - | $122.47 M(-3.9%) |
| June 2011 | - | $127.44 M(-5.0%) |
| Mar 2011 | - | $134.15 M(+77.5%) |
| Dec 2010 | $75.56 M(-46.7%) | $75.56 M(-32.9%) |
| Sept 2010 | - | $112.57 M(-11.8%) |
| June 2010 | - | $127.60 M(-4.5%) |
| Mar 2010 | - | $133.62 M(-5.8%) |
| Dec 2009 | $141.81 M | $141.81 M(+21.1%) |
| Sept 2009 | - | $117.09 M(-9.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2009 | - | $129.18 M(-7.5%) |
| Mar 2009 | - | $139.59 M(-18.6%) |
| Dec 2008 | $171.45 M(-1.1%) | $171.45 M(+16.5%) |
| Sept 2008 | - | $147.19 M(-8.0%) |
| June 2008 | - | $160.02 M(-3.8%) |
| Mar 2008 | - | $166.26 M(-4.0%) |
| Dec 2007 | $173.28 M(-46.9%) | $173.28 M(-18.1%) |
| Sept 2007 | - | $211.52 M(-7.4%) |
| June 2007 | - | $228.48 M(-56.5%) |
| Mar 2007 | - | $524.81 M(+61.0%) |
| Dec 2006 | $326.05 M(+3.6%) | $326.05 M(+40.6%) |
| Sept 2006 | - | $231.87 M(-18.9%) |
| June 2006 | - | $285.93 M(-1.0%) |
| Mar 2006 | - | $288.69 M(-8.2%) |
| Dec 2005 | $314.62 M(-5.4%) | $314.62 M(+2.8%) |
| Sept 2005 | - | $306.05 M(+1.4%) |
| June 2005 | - | $301.72 M(-3.7%) |
| Mar 2005 | - | $313.25 M(-5.8%) |
| Dec 2004 | $332.47 M(+5.9%) | $332.47 M(+15.2%) |
| Sept 2004 | - | $288.66 M(+1.2%) |
| June 2004 | - | $285.32 M(-3.0%) |
| Mar 2004 | - | $294.19 M(-6.3%) |
| Dec 2003 | $314.05 M(+14.0%) | $314.05 M(+15.1%) |
| Sept 2003 | - | $272.80 M(+20.2%) |
| June 2003 | - | $226.93 M(-5.9%) |
| Mar 2003 | - | $241.18 M(-12.4%) |
| Dec 2002 | $275.43 M(+134.5%) | $275.43 M(+133.4%) |
| Sept 2002 | - | $118.03 M(-7.5%) |
| June 2002 | - | $127.66 M(+7.4%) |
| Mar 2002 | - | $118.91 M(+1.2%) |
| Dec 2001 | $117.47 M(+3.6%) | $117.47 M(+0.4%) |
| Sept 2001 | - | $116.96 M(-6.2%) |
| June 2001 | - | $124.70 M(-1.2%) |
| Mar 2001 | - | $126.22 M(+11.3%) |
| Dec 2000 | $113.42 M(-15.7%) | $113.42 M(-1.4%) |
| Sept 2000 | - | $115.01 M(-10.8%) |
| June 2000 | - | $128.99 M(-0.4%) |
| Mar 2000 | - | $129.56 M(-3.7%) |
| Dec 1999 | $134.60 M(-13.7%) | $134.60 M(+2.2%) |
| Sept 1999 | - | $131.70 M(+6.8%) |
| June 1999 | - | $123.30 M(-8.9%) |
| Mar 1999 | - | $135.30 M(-13.3%) |
| Dec 1998 | $156.00 M(+45.3%) | $156.00 M(+24.1%) |
| Sept 1998 | - | $125.70 M(+52.7%) |
| June 1998 | - | $82.30 M(-8.0%) |
| Mar 1998 | - | $89.50 M(-16.7%) |
| Dec 1997 | $107.40 M(+5.2%) | $107.40 M(+37.9%) |
| Sept 1997 | - | $77.90 M(-11.3%) |
| June 1997 | - | $87.80 M(-8.5%) |
| Mar 1997 | - | $96.00 M(-6.0%) |
| Dec 1996 | $102.10 M(+9.1%) | $102.10 M(+51.0%) |
| Sept 1996 | - | $67.60 M(-11.9%) |
| June 1996 | - | $76.70 M(-10.4%) |
| Mar 1996 | - | $85.60 M(-8.5%) |
| Dec 1995 | $93.60 M(+100.4%) | $93.60 M(+0.4%) |
| Sept 1995 | - | $93.20 M(+106.2%) |
| Mar 1995 | - | $45.20 M(-3.2%) |
| Dec 1994 | $46.70 M | $46.70 M(-10.4%) |
| Sept 1994 | - | $52.10 M(+44.7%) |
| June 1994 | - | $36.00 M(-16.7%) |
| Mar 1994 | - | $43.20 M |
FAQ
- What is Ligand Pharmaceuticals Incorporated annual total assets?
- What is the all time high annual total assets for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated annual total assets year-on-year change?
- What is Ligand Pharmaceuticals Incorporated quarterly total assets?
- What is the all time high quarterly total assets for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated quarterly total assets year-on-year change?
What is Ligand Pharmaceuticals Incorporated annual total assets?
The current annual total assets of LGND is $787.22 M
What is the all time high annual total assets for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high annual total assets is $1.49 B
What is Ligand Pharmaceuticals Incorporated annual total assets year-on-year change?
Over the past year, LGND annual total assets has changed by +$24.55 M (+3.22%)
What is Ligand Pharmaceuticals Incorporated quarterly total assets?
The current quarterly total assets of LGND is $954.87 M
What is the all time high quarterly total assets for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high quarterly total assets is $2.11 B
What is Ligand Pharmaceuticals Incorporated quarterly total assets year-on-year change?
Over the past year, LGND quarterly total assets has changed by +$185.64 M (+24.13%)